Metraipolis › archive › dc_d47f86d44dcc
Exposure to formaldehyde and asthma outcomes: A systematic review, meta-analysis, and economic assessment — Europe PMC PMID:33788856
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/33788856
- DOI
- 10.1371/journal.pone.0248258
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-05T04:23:10.857Z
- SHA-256 of the archived text
95807f3d9a422fd2a369f0012951f3852c2afe67034ab9a718f4791f1d3b5743- Stable URL of this page
https://metraipolis.com/documento/dc_d47f86d44dcc
How to cite
Exposure to formaldehyde and asthma outcomes: A systematic review, meta-analysis, and economic assessment — Europe PMC PMID:33788856 — Europe PMC (en), https://europepmc.org/article/MED/33788856 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_d47f86d44dcc (Metraipolis archive dc_d47f86d44dcc, sha256 95807f3d9a422fd2a369f0012951f3852c2afe67034ab9a718f4791f1d3b5743)
BibTeX
@misc{dcd47f86d44dcc,
title = {Exposure to formaldehyde and asthma outcomes: A systematic review, meta-analysis, and economic assessment — Europe PMC PMID:33788856},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/33788856},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_d47f86d44dcc; sha256 95807f3d9a422fd2a369f0012951f3852c2afe67034ab9a718f4791f1d3b5743},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33788856. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Every major federal regulation in the United States requires an economic analysis estimating its benefits and costs. Benefit-cost analyses related to regulations on formaldehyde exposure have not included asthma in part due to lack of clarity in the strength of the evidence. Objectives: 1) To conduct a systematic review of evidence regarding human exposure to formaldehyde and diagnosis, signs, symptoms, exacerbations, or other measures of asthma in humans; and 2) quantify the annual economic benefit for decreases in formaldehyde exposure. Methods: We developed and registered a protocol in PROSPERO (Record ID #38766, CRD 42016038766). We conducted a comprehensive search of articles published up to April 1, 2020. We evaluated potential risk of bias for included studies, identified a subset of studies to combine in a meta-analysis, and rated the overall quality and strength of the evidence. We quantified economics benefit to children from a decrease in formaldehyde exposure using assumptions consistent with EPA's proposed formaldehyde rule. Results: We screened 4,821 total references and identified 150 human studies that met inclusion criteria; of these, we focused on 90 studies reporting asthma status of all participants with quantified measures of formaldehyde directly relevant to our study question. Ten studies were combinable in a meta-analysis for childhood asthma diagnosis and five combinable for exacerbation of childhood asthma (wheezing and shortness of breath). Studies had low to probably-low risk of bias across most domains. A 10-μg/m3 increase in formaldehyde exposure was associated with increased childhood asthma diagnosis (OR = 1.20, 95% CI: [1.02, 1.41]). We also found a positive association with exacerbation of childhood asthma (OR = 1.08, 95% CI: [0.92, 1.28]). The overall quality and strength of the evidence was rated as "moderate" quality and "sufficient" for asthma diagnosis and asthma symptom exacerbation in both children and adults. We estimated that EPA's proposed rule on pressed wood products would result in 2,805 fewer asthma cases and total economic benefit of $210 million annually. Conclusion: We concluded there was "sufficient evidence of toxicity" for associations between exposure to formaldehyde and asthma diagnosis and asthma symptoms in both children and adults. Our research documented that when exposures are ubiquitous, excluding health outcomes from benefit-cost analysis can underestimate the true benefits to health from environmental regulations. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-03-31). Identificativi: PMID 33788856 · PMCID PMC8011796 · DOI 10.1371/journal.pone.0248258. Pagina: https://europepmc.org/article/MED/33788856 — https://doi.org/10.1371/journal.pone.0248258. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-05T04:17:33.985Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.